Search for: "Rivas v. State"
Results 101 - 116
of 116
Sorted by Relevance
|
Sort by Date
30 Jan 2008, 7:35 am
However, denial of one petition is reversed where the state court's lack of notification and petitioner's prompt filing after receiving a response to his inquiry to the state court justified tolling. [read post]
3 Apr 2015, 3:26 pm
See Riva v. [read post]
2 Sep 2008, 5:17 pm
State of Tennessee, No. 06-6208 In civil rights suit alleging that city police discriminated against plaintiffs in violation of the Ame [read post]
21 Feb 2019, 11:23 am
Supreme Court in Penry v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Nov 2021, 8:08 am
” “‘Within days’ of the Sept. 19, 2019, receipt of the fourth letter, Houston and Rivas ran it by Reed Smith’s in-house counsel and the California State Bar’s ethics hotline, the panel said. [read post]
29 Nov 2017, 4:23 pm
The annual report states that under Clayton, pursuit of individuals will be the rule rather than the exception.[12] One justification for this strategy is deterrence. [read post]
1 Dec 2017, 2:55 pm
The annual report states that under Clayton, pursuit of individuals will be the rule rather than the exception.[12] One justification for this strategy is deterrence. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
3 Jun 2021, 3:00 am
WATER QUALITY Clarke v. [read post]
3 Jun 2021, 3:00 am
WATER QUALITY Clarke v. [read post]
1 Sep 2021, 3:00 am
The case and the Court’s summary is as follows: County of Butte v. [read post]
1 Sep 2021, 3:00 am
The case and the Court’s summary is as follows: County of Butte v. [read post]
21 Nov 2022, 10:42 am
”[2] Explicitly, the negotiations exclude issues related to market access, investment protection and investor-state dispute settlement.[3] While the text of the Agreement as it stood in November 2022 is not publicly available, its main elements are listed in the box accompanying this article, and it has been described in a relatively recent publication.[4] Box. [read post]
21 Nov 2022, 10:42 am
”[2] Explicitly, the negotiations exclude issues related to market access, investment protection and investor-state dispute settlement.[3] While the text of the Agreement as it stood in November 2022 is not publicly available, its main elements are listed in the box accompanying this article, and it has been described in a relatively recent publication.[4] Box. [read post]
12 May 2012, 10:19 pm
Marcela Gonzalez Rivas, Cornell University, EEUU97. [read post]
